InterCure Ltd.
INCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $239 | $356 | $389 | $220 |
| % Growth | -32.8% | -8.5% | 76.9% | – |
| Cost of Goods Sold | $209 | $250 | $234 | $129 |
| Gross Profit | $30 | $105 | $155 | $91 |
| % Margin | 12.7% | 29.6% | 39.9% | 41.5% |
| R&D Expenses | $0 | $0 | $1 | $1 |
| G&A Expenses | $63 | $64 | $92 | $45 |
| SG&A Expenses | $85 | $86 | $97 | $53 |
| Sales & Mktg Exp. | $22 | $22 | $6 | $8 |
| Other Operating Expenses | $12 | $60 | $7 | $8 |
| Operating Expenses | $97 | $147 | $104 | $63 |
| Operating Income | -$67 | -$42 | $51 | $28 |
| % Margin | -28.1% | -11.7% | 13% | 12.8% |
| Other Income/Exp. Net | -$20 | -$20 | -$7 | -$9 |
| Pre-Tax Income | -$87 | -$61 | $44 | $19 |
| Tax Expense | -$15 | $2 | $0 | $11 |
| Net Income | -$68 | -$62 | $45 | $5 |
| % Margin | -28.4% | -17.4% | 11.5% | 2.1% |
| EPS | -1.42 | -1.36 | 0.99 | 0.12 |
| % Growth | -4.4% | -237.4% | 725% | – |
| EPS Diluted | -1.42 | -1.36 | 0.99 | 0.11 |
| Weighted Avg Shares Out | 48 | 46 | 45 | 38 |
| Weighted Avg Shares Out Dil | 48 | 46 | 45 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $5 | $1 | $0 |
| Interest Expense | $21 | $24 | $15 | $5 |
| Depreciation & Amortization | $15 | $13 | $12 | $7 |
| EBITDA | -$51 | -$24 | $70 | $31 |
| % Margin | -21.5% | -6.7% | 18.1% | 14.2% |